Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD

ClinicalTrials.gov ID: NCT05556824

Public ClinicalTrials.gov record NCT05556824. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 7:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center Study of Panosyl-Isomaltooligosaccharides (PIMO) Adjunctive to Proton Pump Inhibitor (PPI) Therapy to Treat Gastroesophageal Reflux Disease (GERD) in Subjects Who Are PPI-Responders or PPI-Partial Responders

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will be conducted as a multi-center, randomized, double-blind, placebo-controlled trial to evaluate the effect of MHS-1031 on heartburn-free days in subjects with GERD-related heartburn symptoms.

Study identification

NCT ID
NCT05556824
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Microbiome Health Sciences
Industry
Enrollment
255 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 3, 2023 (Actual)
Primary completion
May 27, 2026 (Actual)
Completion
May 27, 2026 (Actual)
Last update posted
Jul 27, 2026

2023 – 2026

United States locations

U.S. sites
18
U.S. states
9
U.S. cities
16
Facility City State ZIP Site status
Elite Clinical Studies LLC Phoenix Arizona 85018 —
Angel City Research Los Angeles California 90010 —
Wr-Msra, Llc Lake City Florida 32055 —
A Positive Clinical Research Miami Florida 33186 —
Advanced Gastroenterology Associates LLC Palm Harbor Florida 34684 —
Health Synergy Clinical Research West Palm Beach Florida 33407 —
West Palm Quality Research (WPQR) West Palm Beach Florida 33407 —
EmVenio-Georgia (EMGA) Atlanta Georgia 30345 —
WR-Mount Vernon Clinical Research (MVCR) Sandy Springs Georgia 30328 —
Gastroenterology Associates of Western Michigan PLC (WMCR) Wyoming Michigan 49519 —
M3 Wake Research (CPOR) Raleigh North Carolina 27612 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
SMS Clinical Research (SMSR) Mesquite Texas 75149 —
A and U Family Medicine (NCR) Sugar Land Texas 77479 —
University of Virginia Health System Charlottesville Virginia 22908 —
Charlottesville Medical Research Center Charlottesville Virginia 22911 —
Digestive Disease and Liver Specialists Norfolk Virginia 23502 —
GI Research Partners, LLC Richmond Virginia 23236 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05556824, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 27, 2026 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05556824 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →